JanssenÂs Stelara has gained FDA approval for use in patients with CrohnÂs disease who have failed treatment or were intolerant to a TNF blocker drug.The monoclonal antibody drug targets interleukin IL12 and IL23 and is already approved in moderate to seve...
↧